Maravai Lifesciences Holdings Stock Probability of Future Stock Price Finishing Over 32.20
| MRVI Stock | USD 5.92 0.30 5.34% |
Maravai |
Maravai Lifesciences Target Price Odds to finish over 32.20
The tendency of Maravai Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 32.20 or more in 90 days |
| 5.92 | 90 days | 32.20 | close to zero percent |
Based on a normal probability distribution, the odds of Maravai Lifesciences to move over $ 32.20 or more in 90 days from now is close to zero percent (This Maravai Lifesciences Holdings probability density function shows the probability of Maravai Stock to fall within a particular range of prices over 90 days) . Probability of Maravai Lifesciences price to stay between its current price of $ 5.92 and $ 32.20 at the end of the 90-day period is about 88.72 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.05 . This indicates Maravai Lifesciences Holdings market returns are responsive to returns on the market. As the market goes up or down, Maravai Lifesciences is expected to follow. Additionally Maravai Lifesciences Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Maravai Lifesciences Price Density |
| Price |
Predictive Modules for Maravai Lifesciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Maravai Lifesciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Maravai Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Maravai Lifesciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Maravai Lifesciences is not an exception. The market had few large corrections towards the Maravai Lifesciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Maravai Lifesciences Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Maravai Lifesciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.56 | |
β | Beta against Dow Jones | 1.05 | |
σ | Overall volatility | 1.37 | |
Ir | Information ratio | -0.09 |
Maravai Lifesciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Maravai Lifesciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Maravai Lifesciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Maravai Lifesciences generated a negative expected return over the last 90 days | |
| Maravai Lifesciences has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 288.94 M. Net Loss for the year was (119.03 M) with profit before overhead, payroll, taxes, and interest of 714.04 M. | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Disposition of 4363 shares by Rebecca Buzzeo of Maravai Lifesciences at 4.42 subject to Rule 16b-3 |
Maravai Lifesciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Maravai Stock often depends not only on the future outlook of the current and potential Maravai Lifesciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Maravai Lifesciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 131.9 M | |
| Cash And Short Term Investments | 575 M |
Maravai Lifesciences Technical Analysis
Maravai Lifesciences' future price can be derived by breaking down and analyzing its technical indicators over time. Maravai Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Maravai Lifesciences Holdings. In general, you should focus on analyzing Maravai Stock price patterns and their correlations with different microeconomic environments and drivers.
Maravai Lifesciences Predictive Forecast Models
Maravai Lifesciences' time-series forecasting models is one of many Maravai Lifesciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Maravai Lifesciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Maravai Lifesciences
Checking the ongoing alerts about Maravai Lifesciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Maravai Lifesciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Maravai Lifesciences generated a negative expected return over the last 90 days | |
| Maravai Lifesciences has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 288.94 M. Net Loss for the year was (119.03 M) with profit before overhead, payroll, taxes, and interest of 714.04 M. | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Disposition of 4363 shares by Rebecca Buzzeo of Maravai Lifesciences at 4.42 subject to Rule 16b-3 |
Check out Maravai Lifesciences Backtesting, Maravai Lifesciences Valuation, Maravai Lifesciences Correlation, Maravai Lifesciences Hype Analysis, Maravai Lifesciences Volatility, Maravai Lifesciences History as well as Maravai Lifesciences Performance. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Maravai Lifesciences. If investors know Maravai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.33) | Earnings Share (1.67) | Revenue Per Share 2.044 | Quarterly Revenue Growth (0.03) | Return On Assets (0.02) |
The market value of Maravai Lifesciences is measured differently than its book value, which is the value of Maravai that is recorded on the company's balance sheet. Investors also form their own opinion of Maravai Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Maravai Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Maravai Lifesciences' market value can be influenced by many factors that don't directly affect Maravai Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Maravai Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Maravai Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maravai Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.